MedPath

WILATE

WILATE

Approved
DIN Number

02286750

Drug Class

Human

Market Date

Apr 29, 2008

Company
HC

octapharma pharmazeutika produktionsges m b h

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02286750
AIG Number0351695002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD06 VON WILLEBRAND FACTOR AND COAG. FACT. VIII IN COMB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification

ACTIVE INGREDIENTS (3)

ANTIHEMOPHILIC FACTOR (HUMAN)Active
Strength: 500 UNIT / 5 ML
Monograph: ANTIHEMOPHILIC FACTOR (HUMAN)
HUMAN PLASMA PROTEINSActive
Strength: 7.5 MG / 5 ML
Monograph: HUMAN PLASMA PROTEINS
VON WILLEBRAND FACTOR (HUMAN)Active
Strength: 500 UNIT / 5 ML
Monograph: VON WILLEBRAND FACTOR (HUMAN)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.